Search results
Needham & Company LLC Reaffirms Buy Rating for Celcuity (NASDAQ:CELC)
ETF DAILY NEWS· 6 days agoNeedham & Company LLC reaffirmed their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a report published on Thursday, Benzinga reports. The firm currently has a $24.00 price ...
Opaleye Management Inc. Sells 70,885 Shares of Protara Therapeutics, Inc. (NASDAQ:TARA) Stock
ETF DAILY NEWS· 6 days agoProtara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report) major shareholder Opaleye Management Inc. sold 70,885 shares of the firm’s stock in a transaction dated Friday, May 17th. The shares ...
Quantitative imaging reveals collagen changes in melanoma tumors during immunotherapy
Medical Xpress· 1 day agoCollagen, a major component of the extracellular matrix, plays a crucial role in tumor development. During the development of tumors ("tumorigenesis"), collagen fibers become linearized and ...
Sarepta Therapeutics (NASDAQ:SRPT) PT Raised to $179.00
ETF DAILY NEWS· 6 days agoSarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its target price hoisted by Mizuho from $145.00 to $179.00 in a report issued on Friday, Benzinga reports. The firm presently has a “ ...
StockNews.com Begins Coverage on Cytosorbents (NASDAQ:CTSO)
ETF DAILY NEWS· 6 days agoStockNews.com initiated coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research note published on Saturday morning. The firm issued a hold rating on the ...
Dynatronics (NASDAQ:DYNT) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 6 days agoStockNews.com assumed coverage on shares of Dynatronics (NASDAQ:DYNT – Free Report) in a research note published on Saturday morning. The firm issued a hold rating on the ...
StockNews.com Initiates Coverage on Pulmatrix (NASDAQ:PULM)
ETF DAILY NEWS· 5 days agoEquities research analysts at StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM – Get Free Report) in a note issued to investors on Saturday. The brokerage ...
Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated at StockNews.com
ETF DAILY NEWS· 5 days agoInvestment analysts at StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research note issued to investors on Saturday.
Needham & Company LLC Reaffirms Buy Rating for Autolus Therapeutics (NASDAQ:AUTL)
ETF DAILY NEWS· 5 days agoNeedham & Company LLC reaffirmed their buy rating on shares of Autolus Therapeutics (NASDAQ:AUTL – Free Report) in a research note released on Friday, Benzinga reports. They ...
Mitsubishi UFJ Asset Management Co. Ltd. Trims Stake in Catalent, Inc. (NYSE:CTLT)
ETF DAILY NEWS· 6 days agoMitsubishi UFJ Asset Management Co. Ltd. trimmed its holdings in shares of Catalent, Inc. (NYSE:CTLT – Free Report) by 0.9% in the 4th quarter, according to the company in its most recent disclosure ...